HIF1A and neoplasm: This paper explained that KT inhibits HIF-1 activation by suppressing mitochondrial oxygen consumption at the electron transport chain and targets tumor angiogenesis by blocking the induction of angiogenic factors (i.e., VEGF) in tumor cells [16].